Terrence Barrett joined the UK HealthCare faculty from Northwestern Memorial Hospital where he had been on staff since 1992 and a professor in the Division of Gastroenterology since 2008. He came to Lexington in June 2013 as Chief of Gastroenterology.
After receiving his medical degree from the University of Illinois, he completed a residency at Rush Presbyterian St. Luke’s Hospital in Chicago. Then completed fellowships in gastroenterology, IBD and immunology at the University of Chicago.
Dr. Barrett is the recipient of numerous prestigious research grants from the National Institutes of Health and the Crohn’s and Colitis Foundation of America. He serves on the editorial board of numerous national and international journals and has authored more than 200 articles, abstracts, book reviews and editorials.
Dr. Barrett specializes in complex inflammatory bowel disease and is a part of a NCI clinical trial for patients with colitis-induced dysplasia.
He has expertise in chromoendoscopy and the evaluation and detection of colitis-induced dysplasia. Dr. Barrett is one of only a few physicians, nationally, who have experience in this procedure. He is available for direct referrals for colonoscopy with chromoendoscopy in patients needing colitis surveillance.
Faculty RankProfessor of Medicine and Microbiology/Immunology
University of Illinois at Chicago
Rush Presbyterian St. Luke's Hospital, Chicago
Gastroenterology, University of Chicago IBD, University of Chicago Immunology, University of Chicago
Certifications and Special Training
American Board of Internal Medicine American Board of Internal Medicine, Gastroenterology
- "Epithelial TNF Receptor Signaling Promotes Mucosal Repair in Inflammatory Bowel Disease." Bradford, E.M.;Ryu, S.H.;Singh, A.P.;Lee, G.;Goretsky, T.;Sinh, P.;Williams, D.B.;Cloud, A.L.;Gounaris, E.;Patel, V.;Lamping, O.F.;Lynch, E.B.;Moyer, M.P.;De Plaen, I.G.;Shealy, D.J.;Yang, G.Y.;Barrett, T.A. Journal of immunology (Baltimore, Md. : 1950) 199, 5 (2017): 1886-1897.
- "Interdependency of EGF and GLP-2 Signaling in Attenuating Mucosal Atrophy in a Mouse Model of Parenteral Nutrition." Feng, Y.;Demehri, F.R.;Xiao, W.;Tsai, Y.H.;Jones, J.C.;Brindley, C.D.;Threadgill, D.W.;Holst, J.J.;Hartmann, B.;Barrett, T.A.;Teitelbaum, D.H.;Dempsey, P.J. Cellular and molecular gastroenterology and hepatology 3, 3 (2017): 447-468.
- "Predictors of Chronic Opioid Use in Newly Diagnosed Crohn's Disease." Pauly, N.J.;Michailidis, L.;Kindred, M.G.;Flomenhoft, D.;Lofwall, M.R.;Walsh, S.L.;Talbert, J.C.;Barrett, T.A. Inflammatory bowel diseases 23, 6 (2017): 1004-1010.
- "Myo-inositol reduces β-catenin activation in colitis." Bradford, E.M.;Thompson, C.A.;Goretsky, T.;Yang, G.Y.;Rodriguez, L.M.;Li, L.;Barrett, T.A. World journal of gastroenterology 23, 28 (2017): 5115-5126.
- "Epithelial PIK3R1 (p85) and TP53 Regulate Survivin Expression during Adaptation to Ileocecal Resection." Cohran, V.;Managlia, E.;Bradford, E.M.;Goretsky, T.;Li, T.;Katzman, R.B.;Cheresh, P.;Brown, J.B.;Hawkins, J.;Liu, S.X.;De Plaen, I.G.;Weitkamp, J.H.;Helmrath, M.;Zhang, Z.;Barrett, T.A. The American journal of pathology 186, 7 (2016): 1837-46.